After Bernie Sanders Rejected His Campaign Donation, Price-Gouging Exec Fractured His Wrist…or Did He?

Craig Ruttle/AP


Martin Shkreli, the pharmaceutical executive who back in September was caught price-gouging an HIV drug by more than 5,000 percent, is upset with Bernie Sanders.

After attempting to donate to the Vermont senator’s presidential bid—with an offering of $2,700, which Sanders’ campaign swiftly declined—the “most hated man in America” took to Twitter last night to claim that he was so enraged by the public rejection that he punched a wall and was left with a broken wrist.

But Shkreli’s “broken wrist” is probably just one petulant cry for attention. As noted by Twitter user Mike Leeman, who used the power of reverse image search to expose yet another layer of pharma sliminess, it’s looking highly likely that the X-ray posted by Shkreli is actually a stock image of a fractured wrist.

“IDK” is right. Perhaps hoping to detract attention away from the escalation of conflicting medical opinions, soon after this exchange Shkreli posted a photo of himself playing the guitar—no visible signs of a fractured wrist either.

THANK YOU.

We recently wrapped up the crowdfunding campaign for our ambitious Mother Jones Corruption Project, and it was a smashing success. About 10,364 readers pitched in with donations averaging $45, and together they contributed about $467,374 toward our $500,000 goal.

That's amazing. We still have donations from letters we sent in the mail coming back to us, so we're on pace to hit—if not exceed—that goal. Thank you so much. We'll keep you posted here as the project ramps up, and you can join the hundreds of readers who have alerted us to corruption to dig into.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

Share your feedback: We’re planning to launch a new version of the comments section. Help us test it.